GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Change In Payables And Accrued Expense

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense?

Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Chart

Tonghua Dongbao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tonghua Dongbao Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Traded in Other Exchanges
N/A
Address
Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Executives
Cheng Jian Qiu Supervisors
Chang Xiao Hui Director
Li Cong Director
Li Feng Qin Director
Chen Hong senior management
Leng Chun Sheng Director
Li Yi Kui Director
Wang Dian Duo Supervisors
Wang Jun Ye Director
Han Jie Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines